NASDAQ:LFMD LifeMD (LFMD) Stock Price, News & Analysis $4.19 +0.12 (+2.95%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$4.20 +0.00 (+0.12%) As of 05/22/2026 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About LifeMD Stock (NASDAQ:LFMD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LifeMD alerts:Sign Up Key Stats Today's Range$4.10▼$4.3650-Day Range$3.40▼$5.2752-Week Range$2.56▼$15.84Volume722,163 shsAverage Volume1.01 million shsMarket Capitalization$202.64 millionP/E Ratio83.82Dividend YieldN/APrice Target$9.14Consensus RatingModerate Buy Company Overview LifeMD (NASDAQ: LFMD) is a U.S.-based telehealth company that delivers on-demand, membership-based virtual healthcare services. Through its digital platform and mobile applications, LifeMD connects patients with board-certified healthcare providers for diagnosis, treatment and ongoing management of a range of acute and chronic conditions. The company’s core offering centers on personalized care plans supported by prescription fulfillment, lab testing and prescription delivery services. LifeMD’s service portfolio spans several specialty areas, including men’s health, hormonal therapy, weight management and primary care. Patients access virtual consultations, follow-up visits and medication management through a flat-fee membership model. Specialized programs address conditions such as erectile dysfunction, hair loss, thyroid disorders and metabolic health, while integrated pharmacy partnerships allow users to receive prescribed treatments directly at home. Since its founding, LifeMD has expanded through strategic acquisitions of complementary telehealth businesses to broaden its clinical capabilities and patient reach. The company’s brands now encompass platforms focused on preventive care, chronic disease management and women’s health, creating a multi-specialty virtual care network. LifeMD serves patients across the United States and continually invests in digital technology to improve care coordination and patient engagement. Headquartered in Florida, LifeMD went public in early 2021 and trades on the Nasdaq under the ticker LFMD. The company is led by a management team with deep experience in healthcare delivery, digital innovation and telemedicine. LifeMD continues to leverage its unified platform to address evolving consumer preferences for accessible, cost-effective virtual care. AI Generated. May Contain Errors. Read More LifeMD Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks65th Percentile Overall ScoreLFMD MarketRank™: LifeMD scored higher than 65% of companies evaluated by MarketBeat, and ranked 294th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingLifeMD has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 7 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialLifeMD has a consensus price target of $9.14, representing about 118.2% upside from its current price of $4.19.Amount of Analyst CoverageLifeMD has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about LifeMD's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth825.00% Earnings GrowthEarnings for LifeMD are expected to grow by 825.00% in the coming year, from $0.04 to $0.37 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeMD is 83.82, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 44.77.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeMD is 83.82, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.28.Price to Book Value per Share RatioLifeMD has a P/B Ratio of 13.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about LifeMD's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.10% of the float of LifeMD has been sold short.Short Interest Ratio / Days to CoverLifeMD has a short interest ratio ("days to cover") of 4.7.Change versus previous monthShort interest in LifeMD has recently increased by 6.76%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLifeMD does not currently pay a dividend.Dividend GrowthLifeMD does not have a long track record of dividend growth. News and Social Media1.3 / 5News SentimentN/A Search Interest20 people have searched for LFMD on MarketBeat in the last 30 days. This is an increase of 43% compared to the previous 30 days.MarketBeat Follows2 people have added LifeMD to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, LifeMD insiders have not sold or bought any company stock.Percentage Held by Insiders18.40% of the stock of LifeMD is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions35.52% of the stock of LifeMD is held by institutions.Read more about LifeMD's insider trading history. Receive LFMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LFMD Stock News HeadlinesLifeMD to Participate in Upcoming Investor ConferencesMay 15, 2026 | globenewswire.comLifeMD, Inc. (LFMD) Q1 2026 Earnings Call TranscriptMay 6, 2026 | seekingalpha.comSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500. | Brownstone Research (Ad)LifeMD Reports First Quarter 2026 ResultsMay 6, 2026 | globenewswire.comLifeMD to Report First Quarter 2026 Financial Results on May 6April 27, 2026 | globenewswire.comLifeMD Shares Rise After Offering Lilly's GLP-1 Obesity PillApril 20, 2026 | marketwatch.comLifeMD® Now Offering Eli Lilly and Company's Foundayo™ (orforglipron), a New GLP-1 Pill for Weight ManagementApril 10, 2026 | globenewswire.comNovo to sell Wegovy subscriptions on Hims, LifeMD, and othersApril 1, 2026 | seekingalpha.comSee More Headlines LFMD Stock Analysis - Frequently Asked Questions How have LFMD shares performed this year? LifeMD's stock was trading at $3.41 at the beginning of 2026. Since then, LFMD shares have increased by 22.9% and is now trading at $4.19. How were LifeMD's earnings last quarter? LifeMD, Inc. (NASDAQ:LFMD) announced its earnings results on Wednesday, May, 6th. The company reported ($0.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by $0.06. The company earned $50.16 million during the quarter, compared to the consensus estimate of $48.84 million. LifeMD had a negative trailing twelve-month return on equity of 150.88% and a net margin of 2.37%. Read the conference call transcript. Who are LifeMD's major shareholders? LifeMD's top institutional investors include Renaissance Technologies LLC (2.31%), Bank of New York Mellon Corp (0.50%), State of Wyoming (0.29%) and Bank of America Corp DE (0.10%). Insiders that own company stock include Justin Schreiber, Nicholas P Alvarez, Bertrand Velge, Marc David Benathen, Jessica Friedeman, Stefan Galluppi and Eric Harold Yecies. View institutional ownership trends. How do I buy shares of LifeMD? Shares of LFMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LifeMD own? Based on aggregate information from My MarketBeat watchlists, some other companies that LifeMD investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Arista Networks (ANET), e.l.f. Beauty (ELF), Adobe (ADBE) and Jabil (JBL). Company Calendar Last Earnings5/06/2026Today5/24/2026Next Earnings (Estimated)8/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 LFMD's financial health is in the Green zone, according to TradeSmith. LFMD has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:LFMD CIK948320 Webwww.lifemd.com Phone(866) 351-5907FaxN/AEmployees230Year Founded2016Price Target and Rating Average Price Target for LifeMD$9.14 High Price Target$10.00 Low Price Target$8.00 Potential Upside/Downside+118.2%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)$0.05 Trailing P/E Ratio83.82 Forward P/E Ratio104.75 P/E GrowthN/ANet Income$14.35 million Net Margins2.37% Pretax Margin-7.94% Return on Equity-150.88% Return on Assets-22.59% Debt Debt-to-Equity RatioN/A Current Ratio1.04 Quick Ratio0.98 Sales & Book Value Annual Sales$193.33 million Price / Sales1.05 Cash FlowN/A Price / Cash FlowN/A Book Value$0.31 per share Price / Book13.52Miscellaneous Outstanding Shares48,363,000Free Float39,464,000Market Cap$202.64 million OptionableOptionable Beta2.03 Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:LFMD) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredYou have until June 1Macroeconomic strategist Dr. Mark Skousen believes June 1 marks a critical turning point for one of the most o...The Oxford Club | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
